dbHCCvar: A comprehensive database of human genetic variations in hepatocellular carcinoma

Human Mutation

Volumn 32, Issue 12, 2011, Pages

  Yu, Xiao Jia ^a,b   Fang, Fang ^a,b   Tang, Chun Lei ^a   Yao, Lei ^a   Yu, Lu ^a   Yu, Long ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Database; DbHCCvar; Genetic variations; Hepatocellular carcinoma

Indexed keywords

ARTICLE; CANCER SURVIVAL; DATA BASE; DATA EXTRACTION; DISEASE FREE SURVIVAL; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC MARKER; GENETIC VARIABILITY; HUMAN; INFORMATION PROCESSING; LIVER CELL CARCINOMA; MEDLINE; PATHOLOGY; PRIORITY JOURNAL; PUBLICATION; RECURRENT DISEASE;

CARCINOMA, HEPATOCELLULAR; DATABASES, GENETIC; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INTERNET; LIVER NEOPLASMS;

EID: 81255168068     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21595     Document Type: Article

References (33)

1. Artinyan A, Mailey B, Sanchez-Luege N, Khalili J, Sun CL, Bhatia S, Wagman LD, Nissen N, Colquhoun SD, Kim J. 2010. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer 116:1367-1377.
2. den Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7-12.
3. El-Serag HB, Rudolph KL. 2007. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557-2576.
4. Farazi PA, DePinho RA. 2006. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6:674-687.
5. Frank SA, Nowak MA. 2004. Problems of somatic mutation and cancer. Bioessays 26:291-299.
6. Frank SA. 2003. Somatic mutation: early cancer steps depend on tissue architecture. Curr Biol 13:R261-R263.
7. He B, Qiu X, Li P, Wang L, Lv Q, Shi T. 2010. HCCNet: an integrated network database of hepatocellular carcinoma. Cell Res 20:732-734.
8. Hussain SP, Schwank J, Staib F, Wang XW, Harris CC. 2007. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 26:2166-2176.
9. Huynh H. 2010. Molecularly targeted therapy in hepatocellular carcinoma. Biochem Pharmacol 80:550-560.
10. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J Clin 61:69-90.
11. Kew MC. 2002. Epidemiology of hepatocellular carcinoma. Toxicology 181-182:35-38.
12. Kirk GD, Lesi OA, Mendy M, Szymanska K, Whittle H, Goedert JJ, Hainaut P, Montesano R. 2005. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. Oncogene 24;5858-5867.
13. Lee HC, Li SH, Lin JC, Wu CC, Yeh DC, Wei YH. 2004. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res 547:71-78.
14. Levine AJ, Oren M. 2009. The first 30 years of p53: growing ever more complex. Nat Rev Cancer 9:749-758.
15. Liang RC, Neo JC, Lo SL, Tan GS, Seow TK, Chung MC. 2002. Proteome database of hepatocellular carcinoma. J Chromatoqr B Analyt Technol Biomed Life Sci 771:303-328.
16. Llovet JM, Burroughs A, Bruix J. 2003. Hepatocellular carcinoma. Lancet 362:1907-1917.
17. London WT, Evans AA, Buetow K, Litwin S, McGlynn K, Zhou T, Clapper M, Ross E, Wild C, Shen FM, Chen GC, M'Boup S. 1995. Molecular and genetic epidemiology of hepatocellular carcinoma: studies in China and Senegal. Princess Takamatsu Symp 25:51-60.
18. Maglott D, Ostell J, Pruitt KD, Tatusova T. 2011. Entrez gene: gene-centered information at NCBI. Nucleic Acids Res 39(Database issue):D52-D57.
19. Rahbari NN, Mehrabi A, Mollberg NM, Müller SA, Koch M, Büchler MW, Weitz J. 2011. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 253:453-469.
20. Sheen IS, Jeng KS, Wu JY. 2003. Is p53 gene mutation an indicatior of the biological behaviors of recurrence of hepatocellular carcinoma? World J Gastroenterol 9:1202-1207.
21. Su WH, Chao CC, Yeh SH, Chen DS, Chen PJ, Jou YS. 2007. OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci. Nucleic Acids Res 35(Database issue):D727-D731.
22. Tanaka S, Arii S. 2010. Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science. Int J Clin Oncol 15:235-241.
23. Thorgeirsson SS, Grisham JW. 2002. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339-346.
24. UniProt Consortium. 2010. The universal protein resource (UniProt) in 2010. Nucleic Acids Res 38(Database issue):D142-D148.
25. Venook AP, Papandreou C, Furuse J, de Guevara LL. 2010. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15(Suppl 4):5-13.
26. Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, Zhang D, Zhou W. 2010. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol 53:508-518.
27. White DL, Li D, Nurgalieva Z, El-Serag HB. 2008. Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol 167:377-389.
28. Whittaker S, Marais R, Zhu AX. 2010. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29:4989-5005.
29. Wong CM, Ng IO. 2008. Molecular pathogenesis of hepatocellular carcinoma. Liver Int 28:160-174.
30. Wong NA, Rae F, Bathgate A, Smith CA, Harrison DJ. 2000. Polymorphisms of the gene for microsomal epoxide hydrolase and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a Caucasian population. Toxicol Lett 115:17-22.
31. Worns MA, Galle PR. 2010. Future perspectives in hepatocellular carcinoma. Dig Liver Dis 42:S302-S309.
32. Wu L, Xu X, Shen J, Xie H, Yu S, Liang T, Wang W, Shen Y, Zhang M, Zheng S. 2007. MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation. J Surg Oncol 96:62-68.
33. Yamada S, Nomoto S, Fujii T, Kaneko T, Takeda S, Inoue S, Kanazumi N, Nakao A. 2006. Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma. Eur J Surg Oncol 32:303-307.